首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1319152

全球微型生物反應器市場 - 2023-2030 年

Global Micro Bioreactor Market - 2023-2030

出版日期: 2023年07月31日 | 出版商:

DataM Intelligence | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概述

全球微型生物反應器市場規模在2022 年達到35 億美元，預計到2030 年將達到72 億美元，2023-2030 年的年複合成長率為9.8%。生物技術和生物製藥研究的進步、對工藝最佳化和品質控制的日益關注以及對高通量篩選需求的不斷成長是預計在預測期內推動市場發展的部分因素。

微型生物反應器是一種小型生物反應器，用於在受控實驗室中培養和觀察微生物、細胞或組織。它是傳統生物反應器的原子演繹，允許研究人員以較小的規模和較少的體積進行試驗。微型生物反應器應用於許多領域，如製藥研究、生物技術、生物工程和教育研究。它們可用於細胞培養、幹細胞研究、藥物開發和操作最佳化等不同領域。

市場動態

微型生物反應器公司的收購增加有望推動市場成長

2022 年12 月6 日，德國默克公司收購了Erbi Biosystems 公司，後者是名為Breez 的2 毫升微型生物反應器平台技術的開發商。該公司總部位於美國馬薩諸塞州。此次收購於12 月1 日完成，通過實現基於細胞的可擴展灌流生物反應器工藝（從2 毫升到2,000 升）以及快速的實驗室規模工藝開發，加強了總部位於達姆施塔特的製藥、化工和生命科學集團在治療蛋白質領域的上游產品組合。

此外，2020 年11 月17 日，貝克曼庫爾特生命科學公司簽署了一項最終協議，收購位於德國Baesweiler 的私營微型生物反應器製造商m2p-labs。 m2p-labs 以其變革性的BioLector 板式微型生物反應器而聞名，該產品支持篩选和生物程序開發的自動化解決方案。因此，從上述因素來看，市場有望在預測期內得到推動。

市場參與者推出越來越多的產品有望推動市場成長

2021 年7 月19 日，CELLINK 旗下公司CYTENA Bioprocess Solutions 推出了S.NEST，這是一種先進的微型生物反應器，可最大限度地促進細胞生長，同時自始至終監控和分析細胞狀況。 CYTENA Bioprocess Solutions 公司以將創新的生物科學技術與一流的軟體開發相結合而著稱，該公司開發的新型微型生物反應器顛覆了細胞系開發（CLD）領域。

微型生物反應器在各種下游應用的細胞系開發（CLD）研究中取得了許多突破性進展，而S.NEST 在增加了即時監控功能後，更是走在了這些進展的前列。它還包括用於往復混合的專利技術、具有獨立環境控制功能的培養室、用於即時監測pH 值和溶解氧的攝像模組、強大的數據分析軟體、與96 孔或24 孔培養板的兼容性，以及四個培養室可同時進行多達384 孔的高通量培養。

CLD 研究人員希望簡化以前需要數週才能完成的升級和擴展工作流程，S.NEST 獨特的懸浮培養方式無疑將為他們帶來持續的氧氣供應。作為CYTENA 廣泛的單細胞儀器組合的一部分，S.NEST 將為世界各地的實驗室提供高效的細胞培養結果。因此，由於上述因素，市場有望在預測期內得到推動。

微型生物反應器缺乏標準化方案預計將阻礙市場成長

微型生物反應器經常採用新技術和新設計，沒有標準的操作程序。這可能導致數據解釋不一致，並使系統或實驗室之間難以共享結果。要使微型生物反應器被廣泛棄用和接受，就必須制定標準化規程和最佳實踐。因此，從上述因素來看，預計在預測期內，市場成長將受到阻礙。

俄烏衝突分析

俄羅斯和烏克蘭之間的持續衝突有可能影響微型生物反應器市場。衝突可能會阻礙跨境科學合作。新技術（包括微型生物反應器）的叛逃往往是由合作探索努力推動的。但是，如果這些合作因衝突而解體或擱置，可能會減緩受影響地區微型生物反應器的放棄和應用。

在衝突期間，探索的優先順序可能會發生變化，以應對眼前的挑戰和慈善需求。分配給科學研究（包括生物技術和醫學）的資金和庫房可能會被轉用於處理衝突的後果。這種探勘重點的轉移可能會對微型生物反應器的需求和總體需求成長產生直接影響。

COVID-19 影響分析：

COVID-19 對全球微型生物反應器市場產生了積極影響。全球對COVID-19 疫苗的迫切需求導致了大量的研發投資。微型生物反應器在疫苗的快速開發和生產中發揮了關鍵作用，可實現有效的工藝最佳化和高產出的疫苗生產。

疫苗研發需求的增加對微型生物反應器的需求產生了積極影響。疫情的爆發凸顯了快速和可擴展生物處理技術的重要性。微型生物反應器因其小規模和自動化能力，已被公認為生物製藥領域的重要工具。由於對快速工藝開發和生產靈活性的需求，對微型生物反應器和相關技術的需求不斷增加。

Market Overview

Global Micro Bioreactor Market reached US$ 3.5 billion in 2022 and is expected to reach US$ 7.2 billion by 2030 growing with a CAGR of 9.8% during the forecast period 2023-2030. The advancements in biotechnology and biopharmaceutical research, growing focus on process optimization and quality control, and rising demand for high-throughput screening are somee of the factors expected to drive the market over the forecast period.

A microbioreactor is a small-scale bioreactor machine used to cultivate and look at microorganisms, cells, or tissue in a controlled laboratory putting. It's an atomic interpretation of the traditional bioreactor that permits researchers to conduct trials on a smaller scale and with less volume. Micro bioreactors are employed in lots of fields, such as pharmaceutical research, biotechnology, bioengineering, and educational research. They are utilized in cell culture, stem cell studies, drug development, and operation optimization, amongst different things.

Market Dynamics

Increasing Acquisitions of Micro Bioreactor Companies is Expected to Drive Market Growth

On December 6, 2022, Germany's Merck acquired Erbi Biosystems, a developer of the 2 ml micro-bioreactor platform technology known as the Breez. The company is based in the American state of Massachusetts. The acquisition, which closed on December 1, strengthens the Darmstadt-based pharmaceuticals, chemicals, and life science group's upstream portfolio in therapeutic proteins by enabling scalable cell-based perfusion bioreactor processes from 2 ml to 2,000 L with rapid lab-scale process development.

Additionally, on November 17, 2020, Beckman Coulter Life Sciences signed a definitive agreement to acquire m2p-labs, a privately held, microbioreactor manufacturer based in Baesweiler, Germany. m2p-labs is best known for its transformative BioLector plate-based micro bioreactors, which support automated solutions for screening and bioprocess development. Thus, from the above factors, the market is expected to drive over the forecast period.

Increasing Product Launches by the Market Players are Expected to Drive Market Growth

On July 19, 2021, CYTENA Bioprocess Solutions, a CELLINK company launched the S.NEST, a state-of-the-art microbioreactor that maximizes cell growth while monitoring and analyzing cell conditions from start to finish. Well-known for combining innovative bioscience technologies with best-in-class software development, CYTENA Bioprocess Solutions has developed its new microbioreactor to disrupt the field of cell line development (CLD).

Micro bioreactors have been instrumental in many research breakthroughs in CLD for a variety of downstream applications, but with the addition of real-time monitoring, the S.NEST is at the forefront of those advances. It also includes patented technology for reciprocating mixing, incubation chambers with individual environmental controls, a camera module for real-time pH and dissolved oxygen monitoring, powerful analytical software to crunch data, compatibility with 96-well or 24-well culture plates, and four chambers for high-throughput culturing of up to 384 wells at once.

CLD researchers looking to streamline upscaling and expansion workflows that previously took weeks to complete will undoubtedly embrace the S.NEST's unique suspension culturing nourished by a continuous supply of oxygen. The S.NEST, as part of CYTENA's extensive portfolio of single-cell instruments, will make highly efficient cell culturing results available to laboratories all over the world. Thus, owing to the above factors, the market is expected to drive over the forecast period.

Lack of Standardized Protocols for Micro bioreactors is Expected to Hamper the Market Growth

Micro bioreactors frequently employ novel technologies and designs, and there are no standard operating procedures for them. This can lead to inconsistencies in data interpretation and make it difficult to share results between systems or laboratories. Standardized protocols and best practices must be developed for micro bioreactors to be widely abandoned and accepted. Thus, from the above factors, the market is expected to hamper market growth over the forecast period.

Russia-Ukraine Conflict Analysis

The ongoing conflict between Russia and Ukraine has the potential to impact the micro bioreactor market. The conflict could hinder cross-border scientific collaborations. The defection of new technologies, including micro bioreactors, is frequently driven by cooperative exploration efforts. However, if these collaborations disintegrate or are put on hold due to the conflict, it may slow down the relinquishment and application of micro bioreactors in the affected regions.

Priorities for exploration may shift during times of conflict to address immediate challenges and philanthropic needs. Funding and coffers that would have been allocated to scientific research, including biotechnology and medicine, could be diverted to dealing with the aftermath of the conflict. This shift in exploration priorities may have an immediate impact on demand for micro bioreactors and overall demand growth.

COVID-19 Impact Analysis:

COVID-19 has positively impacted the global micro bioreactor market. The urgent global need for COVID-19 vaccines has resulted in significant investment in research and development. Micro bioreactors have played a critical role in the rapid development and production of vaccines, allowing for effective process optimization and high-output vaccine campaigners.

This increased demand for vaccine development has positively influenced the demand for micro bioreactors. The outbreak highlighted the importance of quick and scalable bioprocessing technologies. Micro bioreactors have been recognized as valuable tools in biopharmaceutical assiduity due to their small-scale and automated capabilities. The demand for micro bioreactors and related technologies has increased as a result of the need for rapid process development and manufacturing inflexibility.

Segment Analysis

The global micro bioreactor market is segmented based on type, application, and region.

Biopharmaceutical Industry from the Application Segment Account for 32.3% of the Market Share Owing to the Increasing Demand for Biopharmaceutical Products, Flexibility and Scalability, and Technological Advancements in the MicroBioreactors

Micro bioreactors are well-suited for operations in biopharmaceutical exploration, process development, and optimization due to their unique characteristics and advantages. Micro bioreactors allow for the rapid webbing of various cell lines, culture media, and process parameters to optimize bioprocesses. They enable experimenters to estimate multiple experimental conditions at the same time, which speeds up the development of effective and robust bioproduction processes.

Micro bioreactors provide a controlled environment for genetically negotiating cell lines, such as the expression of therapeutic proteins or antibodies. They enable effective evaluation of various gene constructs, selection of high-producing duplicates, and optimization of recombinant protein expression culture conditions.

Micro bioreactors provide a controlled environment for genetically engineering cell lines, including the expression of therapeutic proteins or antibodies. They allow for efficient evaluation of different gene constructs, selection of high-producing clones, and optimization of culture conditions for recombinant protein expression.

For instance, ambr15 is a microscale automated bioreactor system that replicates traditional laboratory-scale bioreactors. The benchtop system is made up of disposable microbioreactor vessels, an automated workstation, and simple software. ambr 15 allows for the automated parallel processing and control of 24 or 48 bioreactor experiments with a single operator. Designed for aseptic operation in a standard laminar airflow biological safety cabinet. When compared to traditional laboratory bioreactors, ambr 15 provides more efficient, consistent, and scalable bioreactor experiments.

Thus, from the above factors, the market segment is expected to hold the largest market share over the forecast period.

Geographical Analysis

North America Accounted for Approximately 39.6% of the Market Share Owing to the Pharmaceutical Companies Wide Presence and a Significant Rise in Micro Bioreactors' Utilization to Produce Novel Ingredients and Drugs for Specific/Uncured Diseases, Strong Investment in Biotechnology and Life Sciences

The North American region's focus on personalized medicine drives the demand for customized cell-based therapies, tissue engineering constructs, and regenerative medicine products. Micro bioreactors play a vital role in the development and production of these personalized therapies by providing a controlled environment for cell culture and process optimization. As the demand for personalized medicine continues to grow, the utilization of micro bioreactors is expected to increase.

The supportive regulatory environment in North America, particularly in the United States, enables faster and more efficient drug development and manufacturing processes. Regulatory agencies like the FDA have shown a willingness to adopt new technologies, including micro bioreactors, which offer benefits in process development, optimization, and cost-effective manufacturing. This favorable regulatory environment reduces barriers to market entry for biopharmaceutical companies utilizing micro bioreactors, thereby driving their adoption.

Competitive Landscape

The major global players in the market include: Sartorius, Stedim, Pall Corporation, M2p-labs, Merck, Applikon Biotechnology, Chemtrix, CerCell, RUAG Space Nyon, PreSens Precision Sensing, and Eppendorf among others.

Why Purchase the Report?

To visualize the global micro bioreactor market segmentation based on type, application, and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of global micro bioreactor market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as Excel consisting of key products of all the major players.

The global micro bioreactor market report would provide approximately 53 tables, 50 figures, and 195 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Type
3.2. Snippet by Application
3.3. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Acquisitions of Micro Bioreactor Companies
  - 4.1.1.2. Increasing Product Launches by the Market Players
- 4.1.2. Restraints
  - 4.1.2.1. Lack of Standardized Protocols for Micro bioreactors
- 4.1.3. Opportunity
  - 4.1.3.1. Emergence of Microfluidics in Personalized Medicine
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID-19
- 6.1.2. Scenario During COVID-19
- 6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers' Strategic Initiatives
6.6. Conclusion

7. By Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 7.1.2. Market Attractiveness Index, By Type
7.2. 24 Parallel Bioreactors*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. 48 Parallel Bioreactors
7.4. Others

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Biopharmaceutical Industry*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%
8.3. Food Industry
8.4. Sewage Treatment
8.5. Biochemical Engineering
8.6. Pharmaceutical Industry
8.7. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
- 9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  - 9.2.5.1. U.S.
  - 9.2.5.2. Canada
  - 9.2.5.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
- 9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  - 9.3.5.1. Germany
  - 9.3.5.2. U.K.
  - 9.3.5.3. France
  - 9.3.5.4. Italy
  - 9.3.5.5. Spain
  - 9.3.5.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
- 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  - 9.4.5.1. Brazil
  - 9.4.5.2. Argentina
  - 9.4.5.3. Rest of South America
9.5. Asia Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
- 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
- 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  - 9.5.5.1. China
  - 9.5.5.2. India
  - 9.5.5.3. Japan
  - 9.5.5.4. Australia
  - 9.5.5.5. Rest of Asia Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
- 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Product Benchmarking
10.3. Company Share Analysis
10.4. Key Developments and Strategies

11. Company Profiles

11.1. Sartorius*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Stedim
11.3. Pall Corporation
11.4. M2p-labs
11.5. Eppendorf
11.6. Merck
11.7. Applikon Biotechnology
11.8. Chemtrix
11.9. CerCell
11.10. RUAG Space Nyon
11.11. PreSens Precision Sensisng